Andrew Walkty
- Molecular Medicine top 0.05%
- Pharmacology top 0.2%
- Epidemiology top 1%
- Infectious Diseases top 1%
- Applied Microbiology and Biotechnology top 0.1%
- Co-authors
- James A. KarlowskyGeorge G. ZhanelPhilippe Lagacé‐WiensHeather J. AdamDaryl J. HobanAlfred S. GinFrank SchweizerSheryl Zelenitsky
- Topics
- Antibiotic Resistance in Bacteria (76 papers)Antibiotics Pharmacokinetics and Efficacy (42 papers)Bacterial Identification and Susceptibility Testing (35 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
Andrew Walkty
118 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Medicine 2.8k
- Pharmacology 1.9k
- Epidemiology 1.6k
- Infectious Diseases 1.0k
- Applied Microbiology and Biotechnology 877
Countries citing papers authored by Andrew Walkty
This map shows the geographic impact of Andrew Walkty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Walkty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Walkty more than expected).
Fields of papers citing papers by Andrew Walkty
This network shows the impact of papers produced by Andrew Walkty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Walkty. The network helps show where Andrew Walkty may publish in the future.
Co-authorship network of co-authors of Andrew Walkty
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Walkty. A scholar is included among the top collaborators of Andrew Walkty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Walkty. Andrew Walkty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 6 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 6 | |
| 7 | 8 | |
| 8 | 15 | |
| 9 | 18 | |
| 10 | 7 | |
| 11 | 10 | |
| 12 | 11 | |
| 13 | 37 | |
| 14 | Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacillibreakdown → | 311 |
| 15 | 38 | |
| 16 | 118 | |
| 17 | 2 | |
| 18 | 16 | |
| 19 | In Vitro Activity of Ceftobiprole Against Pseudomonas aeruginosa Isolates Obtained from Patients in Canadian Hospitals | 0 |
| 20 | 286 |
About Andrew Walkty
Andrew Walkty is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 126 papers that have together received 4.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (76 papers), Antibiotics Pharmacokinetics and Efficacy (42 papers) and Bacterial Identification and Susceptibility Testing (35 papers). The work is most often cited by research in Molecular Medicine (2.8k citations), Applied Microbiology and Biotechnology (877 citations) and Pharmacology (1.9k citations). Andrew Walkty has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include James A. Karlowsky, George G. Zhanel, Philippe Lagacé‐Wiens, Heather J. Adam, Daryl J. Hoban, Alfred S. Gin, Frank Schweizer, Sheryl Zelenitsky, Melanie Baxter and Joseph P. Lynch. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.